QDIS Blog

Here’s an interesting item that somehow escaped me when it was announced and I just now heard about it. Seems Dishman Pharmaceuticals & Chemicals Ltd will purchase the pharmaceutical services division of Solutia (Carbogen and Amcis) for $74.5 million.

• The Hindu Business Line : Dishman to buy Swiss co Solutia’s unit

I had known that Solutia was looking to sell this unit a year or so ago but, Solutia then changed their mind and wasn’t going to sell the pharma unit. In the Sept 5, 2005 issue of Chemical and Engineering News under business concentrates, they announced the sale of the consulting arm to Paul Woitach (Pharmaceutical Advisors) but at the end of that short article it states that earlier this year (2005) Solutia decided to hold on to these businesses. Seems they didn’t stick to that decision for very long.

Since I have people I know who work at both Carbogen and Amcis and have done projects with them in the past I truly hope things work out for the best for them. I have always had a pleasant experience in my dealings with them and hope that doesn’t change.

Indian pharmaceutical companies seem to be buying up contract manufacturers of late. Recently, Shasun Chemicals & Drugs bought Rhodia.

• Shasun acquires Rhodia Pharma custom synthesis business

Avecia also sold their contract manufacturing to Nicholas Piramal India Ltd back in Oct of 2005.

• The Hindu Business Line : Nicholas Piramal buys Avecia

I think this shows how serious the pharma industry in India is in being seen by the world as a leading player in the pharma arena. With all the growth in outsourcing and India being one of those places these acquisitions make sense.

Email Ed Vawter

Bookmark it with: | del.icio.us | Digg it | Furl | Simpy | Spurl | My Yahoo! |